Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis...

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS).
• Small non-coding RNAs (sncRNAs), including microRNAs (miRNAs), are implicated in MS pathogenesis.
• Understanding sncRNA profiles in different biological compartments is crucial for MS research.

Purpose of the Study:

• To comprehensively analyze all classes of sncRNAs in matched samples from MS patients and controls.
• To investigate the differential expression of sncRNAs in peripheral blood mononuclear cells (PBMCs) and cerebrospinal fluid (CSF) during different MS disease states.
• To explore the potential role of sncRNAs in regulating pathogenic mechanisms within the CNS.

Main Methods:

• Analysis of sncRNAs (miRNAs, tsRNAs, etc.) in PBMCs, plasma, and CSF cells/supernatant.
• Comparison of sncRNA profiles between relapsing-remitting MS (RRMS) in relapse and remission, secondary progressive MS (SPMS), and neurological disease controls (NINDC, INDC).
• Statistical analysis to identify differentially expressed sncRNAs.

Main Results:

• Widespread changes in miRNAs and sncRNA fragments (snRNAs, snoRNAs, tRNAs) were observed.
• In CSF cells, a significant increase in sncRNAs was found in RRMS relapse compared to remission and in RRMS compared to NINDC.
• Conversely, a significant decrease in sncRNAs was observed in PBMCs from RRMS patients compared to NINDC.

Conclusions:

• A striking contrast exists in sncRNA expression patterns between the CNS and periphery in MS.
• SncRNA-mediated mechanisms, such as alternative splicing and RNA regulation, likely play a key role in the CNS target organ.
• These findings highlight the importance of sncRNAs in MS pathogenesis and suggest compartment-specific regulatory roles.